Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor H.
about
Design and Evaluation of Meningococcal Vaccines through Structure-Based Modification of Host and Pathogen MoleculesStructure-Based Reverse Vaccinology Failed in the Case of HIV Because it Disregarded Accepted Immunological TheoryHuman factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH bindingMutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa.A Mutant Library Approach to Identify Improved Meningococcal Factor H Binding Protein Vaccine Antigens.Functional Analysis of the Human Antibody Response to Meningococcal Factor H Binding ProteinA meningococcal vaccine antigen engineered to increase thermal stability and stabilize protective epitopes.Impaired Immunogenicity of Meningococcal Neisserial Surface Protein A in Human Complement Factor H Transgenic Mice.Meningococcal Factor H Binding Protein Vaccine Antigens with Increased Thermal Stability and Decreased Binding of Human Factor H.Does binding of complement factor H to the meningococcal vaccine antigen, factor H binding protein, decrease protective serum antibody responses?fH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations.Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice.Nonfunctional variant 3 factor H binding proteins as meningococcal vaccine candidates.Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen.
P2860
Q27675010-3CF4E354-B9CC-434E-91F9-E4D77E7AD90CQ28071559-CB62F681-CDC3-4622-B480-54386502BA0BQ34237895-6068FCF6-2FB7-4FAD-8225-123A26549EE4Q34785389-E9B23E31-6166-4C43-9218-16B85B5CB52FQ35658277-7D101B14-C04B-4934-8523-D30DEE41C9BDQ35777766-882CBAB8-3CD9-4B55-B593-6DB297885305Q36354851-933A07CC-3A8B-42B0-A1C5-B65F9144706AQ36513433-4F39CDD9-54E5-4F54-820D-FE61C93088E3Q37002310-F1494185-A2AD-4A59-A267-5B480DB4B4E7Q37124721-F77F3E03-8A7D-4F61-AC56-24197C43F0E4Q37130358-29B78630-8244-405B-AC54-DCBCF17020DCQ37401146-74CBA0F3-4C78-4CE5-8AEF-13D17CF8C046Q38328071-F31765A8-DAB0-4AD0-A068-11D77B7810BDQ38363907-67034B3F-FE75-4A41-A820-2291391CF28F
P2860
Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor H.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Design of meningococcal factor ...... ind human complement factor H.
@ast
Design of meningococcal factor ...... ind human complement factor H.
@en
type
label
Design of meningococcal factor ...... ind human complement factor H.
@ast
Design of meningococcal factor ...... ind human complement factor H.
@en
prefLabel
Design of meningococcal factor ...... ind human complement factor H.
@ast
Design of meningococcal factor ...... ind human complement factor H.
@en
P2093
P2860
P356
P1476
Design of meningococcal factor ...... ind human complement factor H.
@en
P2093
Dan M Granoff
Peter T Beernink
Rolando Pajon
P2860
P304
P356
10.1128/IAI.00103-12
P407
P577
2012-05-21T00:00:00Z